Unliganded thyroid hormone (TH) receptors (TRs) and other nuclear receptors (NRs) repress transcription of hormone-activated genes by recruiting corepressors (CoRs), such as NR CoR (N-CoR) and SMRT. Unliganded TRs also activate transcription of THrepressed genes. Some evidence suggests that these effects also involve TR͞CoR contacts; however, the precise reasons that CoRs activate transcription in these contexts are obscure. Unraveling these mechanisms is complicated by the fact that it is difficult to decipher direct vs. indirect effects of TR-coregulator contacts in mammalian cells. In this study, we used yeast, Saccharomyces cerevisiae, which lack endogenous NRs and NR coregulators, to determine how unliganded TRs can activate transcription. We previously showed that adenovirus 5 early-region 1A coactivates unliganded TRs in yeast, and that these effects are blocked by TH. We show here that human adenovirus type 5 early region 1A ( 
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nuclear receptor coregulators ͉ gene activation N uclear receptors (NRs), including thyroid hormone (TH) receptors (TRs), are hormone-regulated transcription factors (1) (2) (3) . TRs control growth, development, and homeostasis by binding to TH response elements (TREs) in target promoters and modulating transcription. Unliganded TRs repress THactivated genes by recruiting corepressors (CoRs) such as NR corepressor (N-CoR) and silencing mediator for retinoid and TRs (SMRT)͞TR-associated corepressor 2 (TRAC2) (4) (5) (6) . Both N-CoR and SMRT are modular proteins and are comprised of N-terminal repressor domains (RDs), which bind other CoR complex components such as SIN3 and histone deacetylases, and C-terminal NR interacting domains (IDs; Fig. 1) (7) . TRs directly contact short hydrophobic CoR-NR interaction (CoRNR) box motifs (CBMs; consensus I͞LXXI͞H͞ LIXXXI͞L) that are reiterated two or three times within the C-terminal ID and adopt a three-turn ␣-helical structure that docks into a hydrophobic surface on the unliganded TR ligandbinding domain (7) (8) (9) (10) (11) (12) (13) . TH, predominantly triiodothyronine (T 3 ), activates transcription by enhancing packing of TR Cterminal helix 12 over the lower part of the CoR-binding surface, simultaneously promoting CoR release and completing formation of a binding site for coactivators, such as the p160s and TRAP 220 (7).
In contrast, many TR-regulated genes are stimulated by unliganded TR and repressed by T 3 (2) . These TR actions are physiologically important. For example, unliganded TRs activate the thyroid-stimulating hormone (TSH) and pro-TSH releasing hormone promoters, and T 3 represses transcription of both genes to mediate feedback inhibition of TH synthesis. Furthermore, actions of liganded TRs to repress gene expression are relatively common; in liver, approximately two-thirds of TR-regulated genes in mouse liver are repressed by T 3 (14) .
Some evidence suggests that unliganded TRs activate T 3 -repressed genes by binding CoRs (12, (15) (16) (17) . Thus, TR mutations that either block or enhance CoR binding exert parallel effects on transcriptional activation by unliganded TRs. Furthermore, CoR overexpression potentiates unliganded TR activity in these settings. Nevertheless, the reasons that a CoR might be able to activate transcription in some contexts are not clear. One group proposed that TR-CoR complexes activate gene transcription indirectly by sequestration of limiting levels of histone deacetylases (HDACs) associated with other transcription factors at the TSH and pro-TSH releasing hormone promoters (16) . Others observed that TRs bind weakly to unusual TREs within negatively regulated promoters (17) (18) (19) , and it has been proposed that these TREs force the TR-CoR complex to adopt a conformation that recruits auxiliary coactivators, rather than CoR complex components such as HDACs (17) . Indeed, N-CoR binds to the p160 coactivator ACTR, and unliganded TRs may be able to activate transcription by nucleating formation of a complex that contains both coregulators (20) . Thus, overall, the mechanisms proposed to date assume that the stimulatory effects of CoRs on unliganded TRs either are mediated through indirect mechanisms or depend upon promoter-context-specific contributions from additional NR coregulators.
CoR genes are differentially spliced and can encode both full-length CoRs and truncated variants that retain C-terminal IDs but lack N-terminal RDs (4, 6, (21) (22) (23) . Transfection of a gene encoding the truncated N-CoR variant (N-CoR I ; amino acids 1539-2441; Fig. 1 ) reverses transcriptional repression by unliganded TRs at T 3 -inducible reporters and targeted expression of N-CoR I in livers of transgenic mice activates T 3 -inducible genes in the absence of TH (21, 22) . Based on these observations, it has been proposed that N-CoR I acts as dominant negative inhibitor of unliganded TR action by displacing endogenous N-CoR and SMRT from the TR CoR-binding surface. However, two groups found that N-CoR I potentiates unliganded TR action at the negatively regulated pro-TSH-releasing hormone promoter (19, 21) . Although the effects of full-length N-CoR and N-CoR I were not directly compared in these studies, this finding suggests that N-CoR I may not behave exclusively as a dominant negative inhibitor of unliganded TRs, and that it is able to modulate TR activity by different mechanisms.
It is difficult to determine the precise functional consequences of particular TR-coregulator interactions in mammalian cells, because of complicating effects of endogenous NR coregulators. We have therefore used the budding yeast Saccharomyces cerevisiae to reconstruct individual TR transcription complexes and analyze their activities (24) (25) (26) ; yeast contains conserved eukaryotic general transcription factors and chromatin remodeling enzymes but lacks endogenous NRs and NR coregulators (27) (28) (29) (30) (31) (32) . Although coexpression of TRs and p160s was sufficient to reconstitute T 3 -dependent transcriptional activation (24, 25) , we also found, surprisingly, an adenovirus-encoded coactivator, human adenovirus type 5 early region 1A (E1A), behaves as a specific coactivator for unliganded TRs in yeast, thereby establishing a model to dissect how unliganded TRs activate transcription (26) . Here, we investigate how E1A coactivates unliganded TRs and examine the effects of CoRs on TR activity in yeast. We find that E1A contains a consensus CBM and activates unliganded TRs by binding in a similar mode to CoRs. This represents a previously unrecognized observation of a coactivator that binds TR, or other NRs, in the CoR mode. Although full-length N-CoR suppresses E1A-induced unliganded TR activity in yeast, truncated versions of N-CoR that lack N-terminal RDs behave like E1A and coactivate unliganded TRs. We propose that truncated CoRs can be coactivators that mediate transcriptional activation by unliganded TRs in mammalian cells.
Materials and Methods
Yeast Strains and Media. S. cerevisiae wild-type strains YPH499 (MAT␣, ura3, lys2, ade2, trp1, his3, and leu2) were used for transcriptional activation assays. Yeast transformants were grown in minimal medium (0.67% yeast nitrogen base͞2% glucose) routinely supplemented with adenine (40 mg per liter) and lysine (40 mg per liter).
Assay of TR-Dependent Transcriptional Activation in Yeast. hTR␤1-YEp56, hTR␤1-YEp46, E1A 1-82 -pAS1L, and the ␤-gal reporter plasmids TRE-F2 ϫ 1 were described previously (24) (25) (26) . Wildtype and mutant E1A and N-CoR derivatives (4, 21, 26) were expressed as Gal4-DNA-binding domain fusions from the vector pAS1L with LEU2 selectable marker or pRS424-ADH with TRP1 marker E1A , and N-CoR point mutants were generated by site-directed mutagenesis (QuikChange, Stratagene), as described (24) (25) (26) . Selected hTR␤1 ligand-binding domain mutants (12, 33) were subcloned into the Yep46 yeast expression vector as described (24) (25) (26) .
GST Pull-Down Assays and Synthetic Peptide Competition Analyses.
E1A and C-terminal residues 1944-2453 of mouse N-CoR were cloned into the EcoRI͞SalI sites of pGEX4T1 (GST-E1A 1-82 and GST-N-CoR C ). GST-E1A 1-82 and mutants ⌬4-25 or ⌬30-49, or GST-N-CoR C were expressed in Escherichia coli BL21 cells and prepared by standard methods. Full-length 35 S-labeled hTR␤1 was synthesized by in vitro transcription and translation (TNT, Promega). Equivalent amounts of GST or GST-fusion protein were used for in vitro binding assays as described (11) . The sequence of the N-CoR CBM1 competition peptide corresponds to residues 2272-2291: N-ASNLGLEDI-IRKALMGSFDD-C.
Yeast Two-Hybrid Assay. Full-length human TR␤1 and the I280K mutant were expressed as LexA-DNA-binding domain fusions by using the bait vector pBAIT. Sequences encoding amino acids 1-82 of E1A or N-CoR C were expressed as prey in vector pJG4-5. L40 yeast was transformed with bait and prey plasmids and grown overnight in 2% galactose and minimal media containing all essential amino acids except leucine, and tryptophan. Protein-protein interactions were monitored by using the LacZ reporter gene and assayed as Miller units per mg of protein (26) .
Results

E1A Utilizes a CoRNR Box to Bind and Coactivate Unliganded TR.
To delineate the mechanism whereby adenovirus E1A serves as a coactivator for unliganded TRs in yeast, we first defined the E1A residues required for the effect more precisely. We previously determined that E1A amino acids 1-82, expressed as a GAL4 fusion protein to facilitate nuclear localization (E1A 1-82 ), were necessary and sufficient to coactivate unliganded TRs in yeast, irrespective of the nature of the TRE and the presence or absence of the retinoid X receptor TR heterodimer partner (26) . We also found that this effect depends on E1A amino acid residues 4-29. We therefore examined the effects of internal deletions and mutations within E1A 1-82 on TR coactivation and TR binding (Fig. 2) .
In accordance with previous results, E1A coactivated unliganded TR, and this effect was down-regulated by the TR agonist L-triiodothyroacetic acid (Triac), used here because, unlike T 3 , it is taken up efficiently by yeast (Fig. 2 A) . Confirming previous results, there is little effect of Triac in the absence of a cotransfected coregulator. Deletion of residues 1-14, 4-25, and 26-35 (⌬1-14, ⌬4-25, and ⌬26-35, respectively) abolished E1A coactivator function, whereas deletion of residues 2-9 (⌬2-9), 30-49 (⌬30-49), and 48-60 (⌬48-60) did not. Thus, E1A residues 10-29 are essential for coactivation of unliganded TRs.
Inspection of E1A residues 10-29 reveals a sequence that resembles a CoRNR box at amino acids 20-28 (Fig. 1 Lower) . Ala substitutions within this putative CoRNR box at Leu-28 (L28A); Leu-23 and Ile-24 (A2); or Leu-20, Leu-23, Ile-24, and Leu-28 (A4) abrogated TR␤ coactivator function (Fig. 2B) . Other point mutations outside the CoRNR box did not (R2G, H3N, I4A, and V10A), although an Ala substitution at Ile-11 (I11A) did result in some loss of function. Thus, E1A contains a CoRNR box-like sequence required for coactivation of unliganded TR in yeast.
The presence of the E1A CoRNR box suggested an obvious explanation for the ability of E1A to coactivate TRs in the absence, but not in the presence, of TH; E1A binds TRs in a similar mode to CoRs. To confirm this idea, we examined interactions of TR␤ with bacterially expressed E1A in GST pull-down assays in vitro. As expected, TR␤ bound to E1A 1-82 in the absence of TH, and TR␤-E1A 1-82 interactions were abrogated by deletion of E1A amino acid residues 4-25, which removes part of the CoRNR box, but not by deletion of residues 30-49, adjacent to the CoRNR box (Fig. 2C) and by the 2A (L23A and I24A) and 4A (L20A, L23A, I24A, and L28A) point mutations within the CoRNR box (not shown). Furthermore, and contrary to previous reports of TR-E1A interactions in vitro (34) , TR␤ binding to E1A was decreased in the presence of T 3 just as TR-CoR interactions are decreased by T 3 (Fig. 2 C and  D) . Finally, TR␤1 binding to E1A was inhibited by short peptides (20-30 aa) that overlap N-CoR CoRNR box 1 (Fig. 2D ) and also N-CoR CoRNR box 3 and SMRT CoRNR box 1 (not shown). Thus, E1A is a TR coactivator that binds in the typical CoR mode.
N-CoRI Is a Coactivator for Unliganded TR. Because E1A utilizes a CBM to coactivate unliganded TRs, we examined the possibility that naturally occurring CoRs or truncated CoRs might also coactivate unliganded TRs in yeast. Fig. 3A confirms our previous finding that full-length N-CoR (N-CoR FL ) does not coac- tivate unliganded TRs in yeast (26) . N-CoR did inhibit E1A coactivation of TRs, proving that it is expressed in a functional form in this system (not shown) and confirming that it does not behave as a coactivator when bound to the TR CoR-binding site. By contrast, the naturally occurring truncated corepressor NCoR I and an artificial N-CoR truncation that retains two intact CoRNR boxes (N-CoR C amino acids 1944-2453) both behaved as potent coactivators for unliganded TRs. Moreover, activities of both N-CoR truncations were suppressed by Triac, although greater Triac concentrations (10 Ϫ6 M) were required to suppress N-CoR I and N-CoR C activity than E1A activity (10 Ϫ8 M), possibly reflecting the fact that the N-CoR truncations contain multiple CoRNR boxes that could result in tighter binding of the N-CoR truncations to the TR than E1A. Similar results were also observed at a reporter driven by the negatively regulated pro-TSH releasing hormone promoter (not shown), as reported also for E1A (26) .
To determine whether N-CoR CoRNR boxes are required for TR coactivation, we examined the effects of Ala substitutions in all three motifs (Fig. 3B) . N-CoRc contains intact functional CoRNR boxes 1 and 2, and CoRNR box 3 is not functional because of deletion of sequences N-terminal to the core motif that are essential for TR binding (11, 35, 36) . Accordingly, mutations in CoRNR boxes 1 and 2 partially reduced TR coactivation and combinations of mutations in CoRNR boxes 1 and 2 (A201) or in all three CoRNR boxes (A204) abolished TR coactivation. Thus, N-CoR I and another N-CoR truncation that lacks N-terminal RDs behave as coactivators for unliganded TR at positive and negative TREs, and these effects require intact CoRNR boxes. Because yeast lacks endogenous CoRs, we conclude, contrary to existing models, that N-CoR I activates unliganded TRs directly and not simply by displacing endogenous CoRs.
E1A and N-CoRC Coactivate TR by Binding the Corepressor-Binding
Surface. Finally, we examined the requirement for the TR␤ corepressor-binding surface in coactivation by E1A and N-CoR C . Fig. 4A shows that TR␤ mutants, previously characterized for effects upon TR␤͞N-CoR interactions in vitro and unliganded TR␤ activities in transfection assays in vivo, inhibited TR␤ coactivation by E1A and N-CoR C in yeast (12) . Most notably, mutations within residues that lie under the usual position of H12 in liganded TR␤ and form an essential part of the corepressor-binding surface (I280K and C309W) impaired TR coactivation by E1A and N-CoR C . These mutations did not enhance the basal activity of unliganded TRs in yeast in the absence of E1A and N-CoR C (not shown). This suggests that neither cofactor works by displacing an unknown endogenous yeast corepressor that interacts with the TR͞CoR-binding surface on the ligand-binding domain. In addition, two TR␤ mutations (451X and E457K) that impair p160 binding in vitro and p160 coactivation in mammalian cells (33) , and in our hands in yeast (not shown), did not affect coactivation by E1A or N-CoR in this system, confirming that this effect does not require the classical coactivator-binding surface.
TR␤ I280K also exhibited impairment in E1A and N-CoR binding in yeast two-hybrid assays (Fig. 4B ) and in GST pulldowns (not shown), confirming that it inhibits E1A and N-CoR binding directly. Thus, E1A and N-CoR C enhance TR activity by binding the TR CoR-binding surface and not the classical coactivator-binding surface.
Discussion
The yeast system permits us to reconstruct TR-dependent gene regulation pathways and determine effects of particular TRcoregulator interactions in a eukaryotic cell background that is devoid of complicating influences of endogenous NRs or NR coactivators and CoRs (1, 7) . Here, we used yeast to investigate how E1A potentiates the activity of unliganded TRs and how various forms of N-CoR affect TR activity.
Our data indicate that E1A contains a CoRNR box-like sequence (LDQLIEEVL) at amino acids 20-28 that is required for TR coactivation and binding, and that E1A interactions with TR are blocked by T 3 and short CoRNR box peptides in vitro and by mutations in the TR CoR-binding surface in yeast and in vitro. Thus, E1A is a naturally occurring TR coactivator that binds in the CoR mode.
In accordance with previous results, full-length N-CoR does not coactivate unliganded TR in yeast (26) , although it does block E1A action on TR, proving that it is expressed in yeast in a functional form that can compete for the TR CoR-binding surface. These data confirm that the intrinsic activity of fulllength N-CoR is repression.
By contrast, a naturally occurring N-CoR splice variant (NCoR I ) and an artificial N-CoR truncation (N-CoR C ) behave as potent coactivators for unliganded TRs. These effects require CoRNR boxes and the integrity of the TR CoR-binding surface. Thus, the N-CoR C terminus harbors a TR coactivation function whose activity is unmasked by truncation of the N-terminal RDs, and N-CoR I and N-CoR C are, like E1A, coactivators for unliganded TRs.
Our results comprise previously unreported evidence for the existence of specific coactivators that potentiate unliganded TRs by adopting the typical CoR-binding mode. There are several examples of CoRs that inhibit actions of liganded NRs by binding to the typical coactivator-binding surface. These include RIP140, SHP, and DAX1 (37) (38) (39) . Thus, we now have examples of both coactivators and corepressors that bind to the corepressor-binding surface and coactivators and corepressors that bind to the coactivator-binding surface. Although we are not advocating a change in the terminology, it is evident that the current usage of the coactivator-and corepressor-binding sites does not fully convey the properties of these surfaces.
Our data force us to reconsider the interpretation of previous studies yet are also consistent with published results. E1A was originally reported to act as a coactivator for liganded TRs (34) . Our reinspection of the data reveals, however, that E1A also enhanced TR activity in the absence of T 3 . Thus, we propose that E1A enhances unliganded TR activity directly in mammalian cells by contacts with the TR CoR-binding surface and liganded TR activity indirectly, possibly by contacts with TR-associated coactivators. These observations would not exclude the possibility that additional mechanisms could allow E1A to be a coactivator in other contexts. Our data are also consistent with observations that N-CoR I enhances unliganded TR activity in transfections and reactivates the THinducible gene program in livers of thyroidectomized transgenic mice (21, 22) but suggest that these effects could stem, at least in part, from direct TR coactivation rather than reversal of TR dominant-negative activities. Finally, our data suggest a single coherent explanation for the apparently diverse behaviors of N-CoR I at TH-induced and repressed genes; N-CoR I reverses transcriptional inhibition by unliganded TRs at T 3 -induced genes and potentiates transcriptional activation by unliganded TRs at negatively regulated genes, because it is a potent and generalized coactivator for unliganded TRs, irrespective of the nature of the promoter and TRE (19, 21, 22, 26) .
As developed in the Introduction, unliganded TRs can paradoxically activate transcription of negatively regulated genes by binding CoRs, but the reasons that the CoRs can activate transcription in these contexts are not clear. Our demonstration that the N-CoR C terminus harbors a potent TR transcriptional activation function suggests an explanation for these effects. Although the activity of this N-CoR C-terminal transactivation function will often be masked by competing activities of Nterminal RDs and associated proteins in mammalian cells, we propose that unliganded TRs could either activate transcription by preferentially recruiting truncated CoRs such as N-CoR I or, possibly, full-length CoRs that lack associated CoR complex components such as histone deacetylases. We predict that TR͞ CoR contacts would lead to transcriptional activation in either of these contexts.
